Home›Search›American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs

ADIS INT LTD · Switzerland · Est. 2001

ISSN1175-3277eISSN1179-187X

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.876

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.828

Total Works

1,384

Total Citations

27,542

2yr Mean Citedness

3.21

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal publishes research on cardiovascular drug therapies, including mineralocorticoid receptor antagonists for chronic kidney disease, novel agents for heart failure, and PCSK9 inhibitors for atherosclerotic cardiovascular disease. It also covers risk assessment models for venous thromboembolism and the impact of aspirin on cardiovascular outcomes in individuals with elevated lipoprotein(a).

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published2001

Annual Volume~ 73 articles / year

StatusActive (last: 2026)

Total Publications1,384

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

ADIS INT LTD

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1175-3277 / 1179-187X

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2

Medicine (miscellaneous)Q2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Cardiac & Cardiovascular SystemPharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Cardiology and Cardiovascular MedicineMedicine (miscellaneous)

Research Topics (OpenAlex)

Atrial Fibrillation Management and OutcomesLipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular DiseasesHeart Failure Treatment and ManagementBlood Pressure and Hypertension StudiesAcute Myocardial Infarction ResearchVenous Thromboembolism Diagnosis and ManagementDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsCoronary Interventions and Diagnostics